KB HOME KBH

NYSE Price as of Nov 13, 2026 · Fiscal year ended Nov 30, 2025 · Latest quarter Aug 31, 2026

$47.91
$40.92
$67.57
Market cap
$2.91B
P/E (GAAP, TTM)
13.50
P/E (operating)
—
Dividend yield
2.1%
Revenue growth YoY
-20.0%
EPS growth YoY
-34.8%
ROIC
—
Piotroski F-score
4

Three ways to read the P/E

P/E (GAAP, TTM)
13.50

Net income of the last 4 quarters. Includes investment gains and one-time items.

P/E (GAAP, annual)
7.79

Net income of the latest fiscal year. Includes investment gains and one-time items.

P/E (operating)
—

After-tax operating income only: the core business.

P/E (excl. gains)
6.79

Net income after removing identified investment and asset-sale gains.

How it has changed

Values as they were known at each quarter-end. Green = moved in the better direction, red = worse.

Metric 2026Q3 2026Q2Change QoQ 2025Q3Change YoY
Revenue growth YoY (qtr) -27.3% -22.6%-4.7 pts -10.5%-16.7 pts
EPS growth YoY (qtr) -71.3% -65.1%-6.2 pts -30.2%-41.1 pts
Revenue growth (TTM) -17.5% -13.6%-3.9 pts 3.7%-21.2 pts
EPS growth (TTM) -45.4% -36.7%-8.7 pts -0.3%-45.2 pts
P/E (GAAP, TTM) 11.30 12.08-0.78 ——
P/E (operating) — —— ——
P/E (excl. gains) 7.50 10.11-2.61 ——
P/B 0.82 1.11-0.29 ——
ROIC — —— ——
Net margin 6.9% 6.9%0.0 pts 9.5%-2.6 pts
Dividend yield 2.2% 1.6%+0.6 pts ——
EPS (TTM) 4.11 5.18-20.7% 7.53-45.4%
Price $46.46 $62.60-25.8% ——

History by quarter-end

Reported quarters

Quarter endedRevenueQoQYoY EPSQoQYoYNet margin
Aug 31, 2026 $1.30B 16.6% -20.0% 1.05 144.2% -34.8% 5.0%
May 31, 2026 $1.11B 3.3% -27.3% 0.43 -17.3% -71.3% 2.5%
Feb 28, 2026 $1.08B -36.4% -22.6% 0.52 -66.5% -65.1% 3.1%
Nov 30, 2025 * $1.69B 4.6% -15.3% 1.55 -3.7% -38.0% 6.0%
Aug 31, 2025 $1.62B 5.9% -7.5% 1.61 7.3% -21.1% 6.8%
May 31, 2025 $1.53B 9.9% -10.5% 1.50 0.7% -30.2% 7.1%
Feb 28, 2025 $1.39B -30.4% -5.2% 1.49 -40.4% -15.3% 7.9%
Nov 30, 2024 * $2.00B 14.1% 19.5% 2.50 22.5% 35.9% 9.5%
Aug 31, 2024 $1.75B 2.5% 10.4% 2.04 -5.1% 13.3% 9.0%
May 31, 2024 $1.71B 16.5% -3.1% 2.15 22.2% 10.8% 9.9%
Feb 29, 2024 $1.47B -12.3% 6.0% 1.76 -4.3% 21.4% 9.4%
Nov 30, 2023 * $1.67B 5.5% -13.7% 1.84 2.2% -24.6% 9.0%

* Q4 is not filed separately. It is calculated as the fiscal year minus the first three quarters.

All figures

Price & size
Fiscal year end Nov 30, 2025 End date of the latest annual (10-K) report used.
Price date Nov 13, 2026 Date of the latest closing price used.
Price $47.91 Latest closing price.
Market cap $2.91B Price × shares outstanding.
Enterprise value $2.68B Market cap + debt − cash: the price of the whole business.
Shares 60.76M Shares outstanding used for market cap.
Valuation
P/E (GAAP, annual) 7.79 Price ÷ diluted earnings per share of the latest fiscal year. Uses NET income, so it includes investment gains and one-time items. Blank when earnings are negative.
P/E (GAAP, TTM) 13.50 Price ÷ the sum of the last four quarters of diluted EPS. Like P/E but more current. Includes investment gains and one-time items.
P/E (operating) — Market cap ÷ after-tax OPERATING income (latest fiscal year). Core business only: leaves out interest, investment gains and one-time items.
P/E (operating, TTM) — Market cap ÷ after-tax operating income of the last four quarters.
P/E (excl. gains) 6.79 Market cap ÷ net income after removing identified investment and asset-sale gains (after tax). Equals the GAAP P/E when no gains were identified.
PEG — P/E ÷ 3-year EPS growth rate (in %). Below 1 can mean growth is cheap.
PEG (TTM) — TTM P/E ÷ TTM EPS growth rate (in %).
Earnings yield 14.7% Net income ÷ market cap. The inverse of the P/E.
Earnings yield (TTM) 7.4% TTM EPS ÷ price.
P/B 0.75 Market cap ÷ shareholders' equity. Blank when equity is negative.
P/S 0.47 Market cap ÷ revenue of the latest fiscal year.
P/S (TTM) 0.56 Market cap ÷ revenue of the last four quarters.
P/FCF 10.13 Market cap ÷ free cash flow (operating cash flow − capital spending). Blank when FCF is negative.
EV/EBITDA — Enterprise value ÷ EBITDA. Useful for comparing companies with different debt levels.
EV/EBIT — Enterprise value ÷ operating income.
EV/Sales 0.43 Enterprise value ÷ revenue.
Book value / share 64.20 Shareholders' equity ÷ shares.
FCF yield 9.9% Free cash flow ÷ market cap.
Operating vs. one-time earnings
Operating EPS — After-tax operating income per share (latest fiscal year).
Investment gains — Gains (+) or losses (−) on investments inside net income, when the company reported them with the standard tags. Blank = none identified.
Asset-sale gains — One-time gains or losses from selling property, assets or businesses. Blank = none identified.
Non-operating income — Pre-tax income minus operating income: interest, investment results and one-time items combined.
Gains as % of net income 0.0% Identified investment and asset-sale gains (after tax) as a share of net income. A high value means reported earnings are flattered by non-core gains.
Latest quarter & trailing 12 months
Latest quarter Aug 31, 2026 End date of the most recent reported quarter.
Revenue (qtr) $1.30B Revenue of the latest reported quarter.
Net income (qtr) $65.28M Net income of the latest reported quarter.
EPS (qtr) 1.05 Diluted EPS of the latest reported quarter.
Revenue growth YoY (qtr) -20.0% Latest quarter revenue vs the same quarter a year earlier.
Revenue growth QoQ (qtr) 16.6% Latest quarter revenue vs the previous quarter.
EPS growth YoY (qtr) -34.8% Latest quarter EPS vs the same quarter a year earlier.
EPS growth QoQ (qtr) 144.2% Latest quarter EPS vs the previous quarter.
Net income growth YoY (qtr) -40.6% Latest quarter net income vs the same quarter a year earlier.
Net income growth QoQ (qtr) 138.7% Latest quarter net income vs the previous quarter.
Gross margin (qtr) — Gross profit ÷ revenue in the latest quarter.
Operating margin (qtr) — Operating income ÷ revenue in the latest quarter.
Net margin (qtr) 5.0% Net income ÷ revenue in the latest quarter.
Revenue (TTM) $5.18B Revenue of the last four quarters.
Net income (TTM) $227.57M Net income of the last four quarters.
EPS (TTM) 3.55 Sum of the last four quarters of diluted EPS.
Revenue growth (TTM) -20.8% Last four quarters of revenue vs the four quarters before.
EPS growth (TTM) -50.0% Last four quarters of EPS vs the four quarters before.
Net income growth (TTM) -56.1% Last four quarters of net income vs the four quarters before.
Dividends & shareholder returns
Dividend yield 2.1% Dividends paid per share over the last 12 months ÷ price.
Dividend / share (TTM) $1.00 Dividends per share paid over the last 12 months.
Payout ratio 16.3% Dividends per share ÷ EPS. Above 100% means the dividend exceeds earnings.
FCF payout ratio 23.9% Dividends ÷ free cash flow.
Dividend growth (1y) 0.0% Dividends per share vs the same 12-month window a year earlier.
Dividend CAGR (3y) 12.6% Annualised dividend growth over 3 years.
Dividend CAGR (5y) 10.8% Annualised dividend growth over 5 years.
Payments (12m) 4 Number of dividend payments in the last 12 months.
Last ex-dividend date Nov 12, 2026 Most recent ex-dividend date.
Buyback yield 18.6% Share repurchases ÷ market cap.
Shareholder yield 20.7% Dividend yield + buyback yield.
Profitability
Gross margin — Gross profit ÷ revenue (latest fiscal year).
EBITDA margin — EBITDA ÷ revenue.
Operating margin — Operating income ÷ revenue.
Net margin 6.9% Net income ÷ revenue.
FCF margin 4.6% Free cash flow ÷ revenue.
ROE 11.0% Return on equity: net income ÷ shareholders' equity. Blank when equity is negative.
ROA 6.4% Return on assets: net income ÷ total assets.
ROIC — Return on invested capital: after-tax operating income ÷ (equity + debt − cash).
Growth (annual)
Revenue growth (annual) -10.0% Latest fiscal year revenue vs the year before.
Net income growth (annual) -34.5% Latest fiscal year net income vs the year before.
EPS growth (annual) -27.2% Latest fiscal year diluted EPS vs the year before.
Revenue CAGR (3y) -3.3% Annualised revenue growth over 3 fiscal years.
EPS CAGR (3y) -12.2% Annualised EPS growth over 3 fiscal years.
Financial health
Current ratio — Current assets ÷ current liabilities. Above 1 means short-term bills are covered.
Quick ratio — (Current assets − inventory) ÷ current liabilities.
Cash ratio — Cash ÷ current liabilities.
Debt / equity 0.00 Total debt ÷ shareholders' equity. Blank when equity is negative.
Debt / assets 0.00 Total debt ÷ total assets.
Debt / EBITDA — Total debt ÷ EBITDA: roughly how many years of earnings it takes to repay debt.
Net debt / EBITDA — (Debt − cash) ÷ EBITDA. Negative means more cash than debt.
Interest coverage — Operating income ÷ interest expense.
Earnings quality
FCF conversion 67.0% Free cash flow ÷ net income. Above 100% means profits turn into real cash.
Accruals ratio 1.4% (Net income − operating cash flow) ÷ assets. High values can signal low-quality earnings.
Stock comp % revenue 0.7% Share-based compensation ÷ revenue.
R&D % revenue — Research & development spending ÷ revenue.
SG&A % revenue — Selling, general & administrative expense ÷ revenue.
Tax rate used 21.0% Effective tax rate used for after-tax figures (capped 0–35%; 21% when unknown).
Efficiency
Asset turnover 0.93 Revenue ÷ total assets.
Days sales outstanding — Average days to collect payment from customers.
Days inventory — Average days inventory is held.
Days payables — Average days to pay suppliers.
Trading & momentum
52-week high $67.57 Highest price in the last 52 weeks.
52-week low $40.92 Lowest price in the last 52 weeks.
From 52-week high -29.1% How far below the 52-week high the price is (0% = at the high).
Above 52-week low 17.1% How far above the 52-week low the price is.
Avg volume (30d) 675.38K Average shares traded per day over the last 30 days.
Avg $ volume (30d) $32.03M Average dollars traded per day over the last 30 days: a liquidity measure.
Scores
Piotroski F-score 4 Nine yes/no tests of profitability, leverage and efficiency. 8–9 is strong, 0–2 is weak. Missing data counts as a fail.
Altman Z-score — Bankruptcy-risk score. Above 2.99 is safe, below 1.81 is distress. Not meaningful for banks and insurers.
Reported figures (latest fiscal year)
Revenue $6.24B Revenue of the latest fiscal year.
Net income $428.79M Net income of the latest fiscal year.
Diluted EPS 6.15 Diluted earnings per share of the latest fiscal year.
EBITDA — Operating income + depreciation & amortization.
Free cash flow $287.28M Operating cash flow − capital spending.
Total debt $0 Long-term plus current debt.
Cash $230.44M Cash and equivalents.
Equity $3.90B Shareholders' equity.
Total assets $6.68B Total assets.